Skip to content
Stop using now Drug recall · FDA · Published November 21, 2013

Baxter Recalls 100mL Dextrose IV Due to Particulate Matter

Baxter Healthcare recalls 105,216 containers of 5% Dextrose Injection due to foreign particulate matter. Check lot P285288.

🇺🇸 FDA recall #D-1162-2014DrugBaxter Healthcare ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

What happened, in plain English

Baxter Healthcare Corp. is recalling 105,216 containers of 5% Dextrose Injection, USP (100 mL) because the solution contains visible foreign particles. These contaminants include polyester and cotton fibers, adhesive-like mixtures, polyacetal particles, thermally degraded PVC, black polypropylene, and human hair embedded in the plastic bag. The record does not specify a remedy or action for patients. Read more at govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml · Updated October 13, 2026 · FDA enforcement record: FDA #D-1162-2014

Cite this page

“Baxter Recalls 100mL Dextrose IV Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml. Based on FDA recall #D-1162-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1162-2014%22&limit=1).

Why it’s dangerous

The IV solution contains particulate matter such as fibers, plastic fragments, and hair. Introducing these foreign objects directly into a patient's bloodstream via injection can cause serious medical complications, including blockages or infections, although the record does not detail specific injuries.

Who’s affected

Patients receiving intravenous fluids at hospitals, clinics, or other medical facilities nationwide and in Puerto Rico, Singapore, Saudi Arabia, and the United Arab Emirates are affected. Healthcare providers administering this specific lot are most at risk of delivering contaminated fluid.

How to tell if you have this one

Look for 5% Dextrose Injection, USP, in 100 mL single-dose VIAFLEX plastic containers. The product code is 2B0089 and the NDC is 0338-0017-38. Specifically check for Lot # P285288 with an expiration date of 11/13.

  • Brand
    Baxter Healthcare
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.
Recall numberProduct, codes & lotsQuantityNDC
D-1162-20145% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.; Lot #: P285288, Exp 11/13105,216 containers0338-0017-10, 0338-0017-41, 0338-0017-11, 0338-0017-31, 0338-0017-48, 0338-0017-18, 0338-0017-38, 0338-0017-02, 0338-0017-03, 0338-0017-04, 0338-0023-02, 0338-0023-03, 0338-0023-04
D-1163-20140.9% Sodium Chloride Injection, USP, packaged in a) 50 mL Single dose VIAFLEX plastic containers (Product code 2B1308, NDC 0338-0049-31) and b) 100 mL Single dose VIAFLEX plastic containers (Product code 2B1302, NDC 0338-0049-18) and (Product code 2B1309, NDC 0338-0049-38), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.; Lot #: a) P297283, Exp 08/14; b) P292326, Exp 04/14; P293993, Exp 05/14; and P293514, Exp 04/14716,544 containers0338-0049-01, 0338-0049-02, 0338-0049-03, 0338-0049-04, 0338-0049-10, 0338-0049-41, 0338-0049-11, 0338-0049-31, 0338-0049-48, 0338-0049-18, 0338-0049-38, 0338-0043-03, 0338-0043-04
Based on the official FDA remedy

What to do — step by step

  1. Check Inventory

    Verify if you have containers matching Product Code 2B0089, NDC 0338-0017-38, and Lot # P285288.

  2. Stop Use

    Do not administer the fluid if it contains visible particulate matter like fibers or plastic fragments.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Nov 21, 201312. FDA classified it Class I: Mar 14, 201423. Published in FDA’s Enforcement Report: Mar 26, 201434. FDA terminated the recall: Sep 21, 2016420132016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1162-2014 (November 21, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1162-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA